Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 23, 2018 06:00 ET | Source: Sernova Corp

Sernova Completes Oversubscribed Private Placement of $2,754,000

LONDON, Ontario, July 23, 2018 (GLOBE NEWSWIRE) -- Sernova Corp. (TSX-V:SVA) (OTCQB:SEOVF) (FSE:PSH) announces it has completed a non-brokered private placement of $2.754 million, pursuant to which...
July 16, 2018 06:00 ET | Source: Sernova Corp

Sernova Announces $2,000,000 First Closing of Private Placement

Due to Oversubscription, Offering Increased to $2,700,000 THIS NEWS RELEASE IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES.LONDON, Ontario,...
July 05, 2018 06:00 ET | Source: Sernova Corp

Sernova Initiates Patient Screening and Recruitment for its US Clinical Trial for Diabetes

LONDON, Ontario, July 05, 2018 (GLOBE NEWSWIRE) -- Sernova Corp. (“Sernova” or the “Company”) (TSX-V:SVA) (OTCQB:SEOVF) (FSE:PSH) announces that patient screening and recruitment has begun in its...
June 26, 2018 06:00 ET | Source: Sernova Corp

Sernova Announces $2 Million Private Placement Financing

THIS NEWS RELEASE IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES. LONDON, Ontario, June 26, 2018 (GLOBE NEWSWIRE) -- Sernova Corp....
May 14, 2018 06:00 ET | Source: Sernova Corp

Sernova Announces University of Chicago Institutional Review Board (IRB) Approval of the FDA-cleared Therapeutic Cell Pouch Clinical Study

LONDON, Ontario, May 14, 2018 (GLOBE NEWSWIRE) -- Sernova Corp. (TSX-V:SVA) (OTCQB:SEOVF) (FSE:PSH), announces today it has received University of Chicago Institutional Review Board (IRB) approval...
May 08, 2018 06:00 ET | Source: Sernova Corp

Sernova Announces U.S. Phase I/II Cell Pouch Clinical Trial with Prominent Diabetes Clinical Investigator

LONDON, Ontario, May 08, 2018 (GLOBE NEWSWIRE) -- Sernova Corp. (TSX-V:SVA) (OTCQB:SEOVF) (FSE:PSH), announces Dr. Piotr Witkowski, M.D., Ph.D., a leading expert in type 1 diabetes (T1D) and islet...
May 04, 2018 06:00 ET | Source: Sernova Corp

Sernova Announces Results of 2018 Annual General Meeting of Shareholders and New Chief Financial Officer

LONDON, Ontario, May 04, 2018 (GLOBE NEWSWIRE) -- Sernova Corp. (TSX-V:SVA) (OTCQB:SEOVF) (FSE:PSH), announced shareholder approval of all management resolutions brought forward at the 2018 Annual...
February 22, 2018 06:00 ET | Source: Sernova Corp

Sernova’s Cell Pouch Regenerative Medicine Clinical Trial for Patients with Type 1 Diabetes Supported with Continuous Glucose Monitoring Systems

LONDON, Ontario, Feb. 22, 2018 (GLOBE NEWSWIRE) -- Sernova Corp. (TSX-V:SVA) (OTCQB:SEOVF) (FSE:PSH), a clinical stage company developing regenerative medicine technologies for the treatment of...
January 05, 2018 09:40 ET | Source: Sernova Corp

Sernova to Participate at the Biotech Showcase 2018 Healthcare Partnering Conference

LONDON, Ontario, Jan. 05, 2018 (GLOBE NEWSWIRE) -- Sernova Corp (TSX-V:SVA) (OTCQB:SEOVF) (FSE:PSH), a clinical stage regenerative medicine company, today announced that Dr. Philip Toleikis,...
December 11, 2017 06:00 ET | Source: Sernova Corp

Sernova Receives US FDA IND Allowance to Initiate a US Clinical Trial of its Cell Pouch for the Treatment of Type 1 Diabetes

LONDON, Ontario, Dec. 11, 2017 (GLOBE NEWSWIRE) -- Sernova Corp. (TSX-V:SVA) (OTCQB:SEOVF) (FSE:PSH), a clinical stage company developing regenerative medicine technologies for the long-term...

Next Page keyboard_arrow_right